NASDAQ:COSM Cosmos Health (COSM) Stock Price, News & Analysis $0.39 +0.01 (+1.85%) As of 11:43 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Cosmos Health Stock (NASDAQ:COSM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cosmos Health alerts:Sign Up Key Stats Today's Range$0.37▼$0.3950-Day Range$0.19▼$0.4352-Week Range$0.16▼$1.26Volume698,202 shsAverage Volume4.27 million shsMarket Capitalization$39.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cosmos Health Inc. is a global healthcare group that develops, markets and distributes pharmaceutical, nutraceutical and wellness products. The company serves consumers, healthcare professionals and commercial partners through a portfolio that includes prescription and over-the-counter medicines, dietary supplements, vitamins and other health-related products. Cosmos Health markets proprietary nutraceutical brands, including Sky Premium Life, and offers products across categories such as vitamins, minerals, sports nutrition and general wellness. Through its pharmaceutical activities, the company is also involved in the wholesale distribution of medicines, medical products and related healthcare items. Founded in 2009 and formerly known as Cosmos Holdings Inc., the company is headquartered in Chicago and has operations and business relationships spanning the United States, Europe and other international markets. Its European activities have included pharmaceutical distribution and manufacturing partnerships, particularly in Greece. Cosmos Health is led by Chief Executive Officer Greg Siokos, who co-founded the company.AI Generated. May Contain Errors. Read More Cosmos Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreCOSM MarketRank™: 2.07321899736 of 5 starsCosmos Health scored higher than 41% of companies evaluated by MarketBeat, and ranked 673rd out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCosmos Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCosmos Health has only been the subject of 1 research reports in the past 90 days.Read more about Cosmos Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cosmos Health are expected to grow in the coming year, from ($0.21) to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cosmos Health is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cosmos Health is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCosmos Health has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cosmos Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.44% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 0.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 15.27%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCosmos Health does not currently pay a dividend.Dividend GrowthCosmos Health does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment0.27 News SentimentCosmos Health has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Cosmos Health this week, compared to 5 articles on an average week.Search Interest6 people have searched for COSM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows5 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. Company Ownership3.7 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $207,896.00 in company stock, which represents 0.5396% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Cosmos Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $207,896.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders26.15% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.61% of the stock of Cosmos Health is held by institutions.Read more about Cosmos Health's insider trading history. Receive COSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COSM Stock News HeadlinesCosmos Health Inc.: Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 DaysOctober 13 at 1:38 PM | finanznachrichten.deCosmos Health (NASDAQ: COSM) lifts revenue 19% and reaffirms full-year outlookOctober 11 at 9:03 AM | americanbankingnews.comElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11.October 14 at 1:00 AM | Brownstone Research (Ad)Cosmos Health Inc. Reaffirms Revenue Guidance for Fiscal 2026October 10, 2026 | marketscreener.comMCosmos Health Inc. Announces Preliminary Revenue Results for the Third Quarter and Nine Months Ended September 30, 2026October 10, 2026 | marketscreener.comMComparing Amplifon (OTCMKTS:AMFPF) & Cosmos Health (NASDAQ:COSM)October 7, 2026 | americanbankingnews.comGuardant Health, Inc. Announces Cosmos-Mel01 Study Results for Guardant Reveal Liquid Biopsy Test in Resected MelanomaOctober 6, 2026 | marketscreener.comMCosmos Health’s Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 BillionOctober 1, 2026 | usatoday.comSee More Headlines COSM Stock Analysis - Frequently Asked Questions How have COSM shares performed this year? Cosmos Health's stock was trading at $0.4980 at the start of the year. Since then, COSM shares have decreased by 23.1% and is now trading at $0.3829. How were Cosmos Health's earnings last quarter? Cosmos Health Inc. (NASDAQ:COSM) issued its earnings results on Tuesday, August, 18th. The company reported ($0.10) EPS for the quarter, meeting analysts' consensus estimates of ($0.10). The firm earned $19.32 million during the quarter, compared to analyst estimates of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative trailing twelve-month return on equity of 56.88%. When did Cosmos Health's stock split? Shares of Cosmos Health reverse split on Thursday, December 15th 2022.The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Cosmos Health? Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cosmos Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Bollinger Innovations (BINI), Tesla (TSLA), NIO (NIO), NVIDIA (NVDA), Datavault AI (DVLT), Taiwan Semiconductor Manufacturing (TSM) and AMC Entertainment (AMC). Company Calendar Last Earnings8/18/2026Today10/14/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, COSM's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:COSM CIK1474167 Webwww.cosmoshealthinc.com Phone(312) 536-3102FaxN/AEmployees163Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.15 million Net Margins-33.08% Pretax Margin-33.08% Return on Equity-56.88% Return on Assets-18.03% Debt Debt-to-Equity Ratio0.15 Current Ratio1.05 Quick Ratio0.92 Sales & Book Value Annual Sales$65.27 million Price / Sales0.59 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book0.86Miscellaneous Outstanding Shares100,630,000Free Float74,318,000Market Cap$38.74 million OptionableOptionable Beta4.69 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:COSM) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmos Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmos Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
